|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.50 SAR | -2.40% |
|
-2.61% | -3.68% |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
| 11-03 | HSBC Trims Nahdi Medical PT, Affirms Buy Rating | MT |
Business description: Nahdi Medical Company
Number of employees: 6,182
Sales by Activity: Nahdi Medical Company
| Fiscal Period: December | 2020 (SAR) | 2021 (SAR) | 2022 (SAR) | 2023 (SAR) | 2024 (SAR) |
|---|---|---|---|---|---|
Retailing | - | - | - | - | 9.45B |
Group Pharmacies | 6.41B | - | - | - | - |
Agents | 2.23B | - | - | - | - |
Pharma | - | 3.73B | 4.26B | 4.41B | - |
Front Shop | - | 4.3B | 4.28B | 4.13B | - |
Others | - | 34.13M | 74.63M | 172M | - |
Geographical breakdown of sales: Nahdi Medical Company
| Fiscal Period: December | 2020 (SAR) | 2021 (SAR) | 2022 (SAR) | 2023 (SAR) | 2024 (SAR) |
|---|---|---|---|---|---|
Kingdom of Saudi Arabia | 8.64B | 8.07B | 8.62B | 8.71B | 9.45B |
Executive Committee: Nahdi Medical Company
| Manager | Title | Age | Since |
|---|---|---|---|
Yasser Joharji
CEO | Chief Executive Officer | 55 | 31/12/2013 |
| Director of Finance/CFO | 52 | - | |
Khalid Tadlaoui
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/12/2010 |
Samer Bokharee
HRO | Human Resources Officer | 47 | 31/12/2017 |
Hossam Khattab
COO | Chief Operating Officer | 44 | 31/12/2018 |
Composition of the Board of Directors: Nahdi Medical Company
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 31/12/2020 | |
| Director/Board Member | 64 | 17/06/1986 | |
| Director/Board Member | 73 | 31/12/2020 | |
Yasser Joharji
BRD | Director/Board Member | 55 | 31/12/2020 |
Romain Voog
BRD | Director/Board Member | 54 | 31/12/2020 |
Junaid Bajwa
BRD | Director/Board Member | 47 | 31/12/2020 |
| Director/Board Member | 47 | 31/12/2020 |
Company details: Nahdi Medical Company

Other Drug Retailers
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.40% | -2.61% | -23.11% | -48.31% | 3.25B | ||
| -1.64% | -1.42% | +122.93% | -0.97% | 27.65B | ||
| -3.53% | +3.14% | +94.08% | -7.48% | 14.09B | ||
| +0.73% | -4.56% | +10.74% | +18.48% | 6.25B | ||
| -0.19% | +0.42% | -7.19% | +24.52% | 4.96B | ||
| -2.27% | -0.99% | -5.95% | -37.44% | 3.83B | ||
| +1.33% | +3.37% | +39.71% | -43.59% | 3.11B | ||
| -1.43% | -2.94% | -3.70% | +58.38% | 2.86B | ||
| Average | -1.18% | +2.45% | +28.44% | -4.55% | 8.25B | |
| Weighted average by Cap. | -1.64% | +5.53% | +72.30% | -2.48% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4164 Stock
- Company Nahdi Medical Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















